2.0 版间充质干细胞的新来源、分化和治疗用途
New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells 2.0.
机构信息
Department of Biochemistry, College of Medicine, Ewha Womans University, Seoul 07804, Republic of Korea.
Graduate Program in System Health Science and Engineering, Ewha Womans University, Seoul 07804, Republic of Korea.
出版信息
Int J Mol Sci. 2023 Feb 15;24(4):3938. doi: 10.3390/ijms24043938.
Abstract
For the clinical application of mesenchymal stem cells (MSCs), the optimization of biological products (e [...].
摘要
为了实现间充质干细胞（MSCs）的临床应用，需要对生物制品（如……）进行优化。
相似文献
1
New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells 2.0.2.0 版间充质干细胞的新来源、分化和治疗用途
Int J Mol Sci. 2023 Feb 15;24(4):3938. doi: 10.3390/ijms24043938.
2
New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells.间充质干细胞的新来源、分化及治疗用途
Int J Mol Sci. 2021 May 18;22(10):5288. doi: 10.3390/ijms22105288.
3
Mesenchymal stem cells: Biological characteristics and application in disease therapy.间质干细胞：生物学特性及其在疾病治疗中的应用。
Biochimie. 2021 Jun;185:9-21. doi: 10.1016/j.biochi.2021.03.003. Epub 2021 Mar 10.
4
Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus.间充质干细胞：对其在1型糖尿病治疗中应用的日益关注。
J Diabetes Res. 2015;2015:675103. doi: 10.1155/2015/675103. Epub 2015 Oct 20.
5
Autophagy: a promising therapeutic target for improving mesenchymal stem cell biological functions.自噬：提高间充质干细胞生物学功能的有前途的治疗靶点。
Mol Cell Biochem. 2021 Feb;476(2):1135-1149. doi: 10.1007/s11010-020-03978-2. Epub 2020 Nov 16.
6
Mesenchymal stem cells.间充质干细胞。
Cell Transplant. 2011;20(1):5-14. doi: 10.3727/096368910X.
7
Small molecule 2'-deoxycytidine differentiates human umbilical cord-derived MSCs into cardiac progenitors in vitro and their in vivo xeno-transplantation improves cardiac function.小分子 2'-脱氧胞苷在体外将人脐带间充质干细胞分化为心脏祖细胞，其异种移植在体内改善心脏功能。
Mol Cell Biochem. 2020 Jul;470(1-2):99-113. doi: 10.1007/s11010-020-03750-6. Epub 2020 May 15.
8
[Mesenchymal stem cells as a therapeutic tool in tissue and organ regeneration].[间充质干细胞作为组织和器官再生的治疗工具]
Postepy Hig Med Dosw (Online). 2011 Feb 24;65:124-32. doi: 10.5604/17322693.933878.
9
Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease.间充质干细胞归巢以提高肝病的治疗效果。
Stem Cell Res Ther. 2022 May 3;13(1):179. doi: 10.1186/s13287-022-02858-4.
10
Role of Mesenchymal Stem Cells in Cancer Development and Their Use in Cancer Therapy.间质干细胞在癌症发展中的作用及其在癌症治疗中的应用。
Adv Exp Med Biol. 2018;1083:45-62. doi: 10.1007/5584_2017_64.
引用本文的文献
1
Integrating Graphene Oxide and Mesenchymal Stem Cells in 3D-Printed Systems for Drug Delivery and Tissue Regeneration.在用于药物递送和组织再生的3D打印系统中整合氧化石墨烯和间充质干细胞
Pharmaceutics. 2025 Aug 21;17(8):1088. doi: 10.3390/pharmaceutics17081088.
2
Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stromal Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model.源自间充质基质细胞的工程化载ATP细胞外囊泡：体外模型中对抗细胞ATP耗竭的新策略
Int J Mol Sci. 2025 Apr 5;26(7):3424. doi: 10.3390/ijms26073424.
3
Effectiveness of human adipose tissue-derived mesenchymal stem cells expressing alpha-1 antitrypsin gene in liver fibrosis: a study in mice.表达α-1抗胰蛋白酶基因的人脂肪组织来源间充质干细胞在肝纤维化中的有效性：一项小鼠研究
Gastroenterol Hepatol Bed Bench. 2024;17(2):151-160. doi: 10.22037/ghfbb.v17i2.2923.
4
Expansion of human umbilical cord derived mesenchymal stem cells in regenerative medicine.人脐带间充质干细胞在再生医学中的扩增
World J Stem Cells. 2024 Apr 26;16(4):410-433. doi: 10.4252/wjsc.v16.i4.410.
5
Powering prescription: Mitochondria as "Living Drugs" - Definition, clinical applications, and industry advancements.动力处方：线粒体作为“活性药物”——定义、临床应用及行业进展
Pharmacol Res. 2024 Jan;199:107018. doi: 10.1016/j.phrs.2023.107018. Epub 2023 Nov 25.
本文引用的文献
1
Decellularization of Human Pancreatic Fragments with Pronounced Signs of Structural Changes.人胰腺碎片的去细胞化，伴有明显的结构变化迹象。
Int J Mol Sci. 2022 Dec 21;24(1):119. doi: 10.3390/ijms24010119.
2
Effects of Different Basal Cell Culture Media upon the Osteogenic Response of hMSCs Evaluated by Tc-HDP Labeling.不同的骨髓间充质干细胞基础培养条件对 Tc-HDP 标记评估的成骨反应的影响。
Int J Mol Sci. 2022 Jun 3;23(11):6288. doi: 10.3390/ijms23116288.
3
TGFβ-Treated Placenta-Derived Mesenchymal Stem Cells Selectively Promote Anti-Adipogenesis in Thyroid-Associated Ophthalmopathy.转化生长因子β处理的胎盘间充质干细胞选择性促进甲状腺相关眼病中的抗脂肪生成。
Int J Mol Sci. 2022 May 17;23(10):5603. doi: 10.3390/ijms23105603.
4
Connection between Mesenchymal Stem Cells Therapy and Osteoclasts in Osteoarthritis.间充质干细胞治疗与骨关节炎破骨细胞的关系。
Int J Mol Sci. 2022 Apr 23;23(9):4693. doi: 10.3390/ijms23094693.
5
Thrombin Preconditioning Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in Severe Intraventricular Hemorrhage Induced Neonatal Rats.凝血酶预处理可提高骨髓间充质干细胞治疗严重脑室出血诱导的新生大鼠的疗效。
Int J Mol Sci. 2022 Apr 18;23(8):4447. doi: 10.3390/ijms23084447.
6
Autophagy Signaling by Neural-Induced Human Adipose Tissue-Derived Stem Cell-Conditioned Medium during Rotenone-Induced Toxicity in SH-SY5Y Cells.神经诱导的人脂肪组织来源的干细胞条件培养基在鱼藤酮诱导的 SH-SY5Y 细胞毒性中的自噬信号传导。
Int J Mol Sci. 2022 Apr 10;23(8):4193. doi: 10.3390/ijms23084193.
7
Knee and Peri-Knee Tissues of Post Mortem Donors Are Strategic Sources of Mesenchymal Stem/Stromal Cells for Regenerative Procedures.尸体捐献者的膝关节及膝关节周围组织是再生程序中间充质干细胞/基质细胞的重要来源。
Int J Mol Sci. 2022 Mar 15;23(6):3170. doi: 10.3390/ijms23063170.
8
Mesenchymal Stem/Stromal Cells and Their Paracrine Activity-Immunomodulation Mechanisms and How to Influence the Therapeutic Potential.间充质干/基质细胞及其旁分泌活性——免疫调节机制以及如何影响治疗潜力
Pharmaceutics. 2022 Feb 9;14(2):381. doi: 10.3390/pharmaceutics14020381.
9
Density-Dependent Differentiation of Tonsil-Derived Mesenchymal Stem Cells into Parathyroid-Hormone-Releasing Cells.扁桃体来源间充质干细胞向甲状旁腺素分泌细胞的密度依赖性分化。
Int J Mol Sci. 2022 Jan 10;23(2):715. doi: 10.3390/ijms23020715.
10
Cadaveric Stem Cells: Their Research Potential and Limitations.尸体干细胞：它们的研究潜力与局限性
Front Genet. 2021 Dec 22;12:798161. doi: 10.3389/fgene.2021.798161. eCollection 2021.
Zotero 插件